While several studies have implicated the PI3K/Akt/GSK3 pathway in cell death after transient [28-30] or permanent [31] cerebral ischemia, it remains unclear whether modification of this pathway after pMCAO can ameliorate the effects of ischemic damage. This evidence concerns the gene AKT1 and brain ischemia.